Statistics from Altmetric.com
A 69-year-old man was referred by his physician for a routine fundus evaluation. He was known to have type 2 diabetes mellitus, hypertension and left-sided hemiparesis due to a history of stroke. Best-corrected visual acuity was 20/25; N6 in both eyes. Fundus evaluation indicated the presence of a few microaneurysms in the posterior pole and preretinal haemorrhages, just above the arcades, in both eyes (figure 1A,B). He was imaged using wide-angle swept source optical coherence angiography (SS OCTA) 12×12 mm field of view (PLEX Elite 9000; Carl Zeiss Meditec, Dublin, California, USA) which showed the presence of neovascular fronds hidden behind preretinal haemorrhages and adjacent capillary non-perfusion areas in both eyes (figure 2A,B).
He underwent panretinal photocoagulation in both eyes based on the diagnosis of proliferative diabetic retinopathy (PDR) with the detection of clinically non-apparent neovascularisation by wide-angle SS OCTA.
Fundus fluorescein angiography (FFA) was considered the gold standard for the detection of neovascularisation. However, wide-angle OCTA has advantages over FFA as it has a widefield of view, non-invasive imaging and employs dye less visualisation techniques.
Wide-angle SS OCTA is a three-dimensional imaging modality which detects retinal neovascularisation, by observing red blood cell motion signals inside the neovascular fronds above the internal limiting membrane, and plots the neovascularisation changes in two-dimensional images.1 2
Wide-angle SS OCTA, with its automated segmentation techniques, has the ability to detect the presence of multiple retinal pathologies, such as capillary non-perfusion, preretinal haemorrhage and the presence of neovascularisation at different layers in the same area. This may not be clinically apparent and is often missed.3 4
When the simulated widefield SS OCTA field of view was placed over the ultra-widefield FFA, most eyes had comparable results in the detection of neovascularisation among the two modalities hence ultra-widefield OCTA may be the only imaging needed to manage PDR.5 6
Widefield colour fundus imaging and wide-angle SS OCTA can detect eyes with higher grades of diabetic retinopathy (DR) when compared with clinical examination alone.7 Better visualisation of the peripheral retina using ultra-widefield imaging improves diagnosis and classification of diabetic retinopathy; hence wide-angle SS OCTA could become a routine mode of documentation in the near future.8
Widefield OCTA allowed us to correctly diagnose the patient with proliferative diabetic retinopathy. The peripheral new vessels could have been missed on clinical fundus examination alone.
Patients with multiple comorbidities are more likely to miss their follow-up appointments. They may be medically unfit to have FFA and may also be prone to dye related complications.
These patients may have a faster rate of diabetic retinopathy progression and may only return to the clinic for review when the vision has drastically deteriorated. It is, therefore, very important to diagnose and treat these patients during the same clinic visit where possible.
A patient-friendly, non-invasive and safe modality is therefore highly appropriate for use in medically unfit patients with diabetes. The wide-angle SS OCTA fulfils this role by detecting peripheral diabetic neovascularisation, which will cause devastating vision loss if left untreated.
The presence of preretinal haemorrhages indicate the possibility of underlying clinically non-apparent neovascularisation in the proliferativediabetic retinopathy (PDR).
Wide-angle swept source opticalcoherence angiography is a quick and non-invasive diagnostic modality in the detection of clinically non-apparent neovascularisation in PDR.
Contributors AB collected images and prepared manuscript draft. PKR managed the case and edited the manuscript.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Parental/guardian consent obtained.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.